Advanced Physician Search: Amyloid

202506209

Brief Summary

Open-label Phase 1b/2 study with primary objective of this study is to evaluate the safety, tolerability and efficacy of AZD0120 in participants with light chain (AL) amyloidosis.

Protocol Interventions

Drug: AZD0120